However, the previously observed changes in FNDC5 levels depend on the animal model of depression used, and, for example, in the model induced by administration of corticosterone, even increased expression of FNDC5 was observed in the frontal cortex in contrast to the decrease in this factor in the model based on LPS administration. The gene discussed is FNDC5; the disease is depressive symptom measurement.